Journal of Antimicrobial Chemotherapy · 1996 · 266 citations · 4 references
PharmacyPharmacokineticsPharmacologyBioavailabilityDrug DeliveryPulmonary Drug DeliveryAntimicrobial Penetration Into TissuesPharmacokinetics Of AntimicrobialsPulmonary PermeationPulmonary PharmacokineticsAntibiotic Penetration Into TissueContinuous Infusion AntibioticsContinuous Infusion PharmacologyContinuous Subcutaneous InfusionLung Absorption KineticsLung Tissue BindingPulmonary Absorption KineticsVancomycin Pharmacodynamics
Vancomycin penetration into lung tissue was evaluated in thirty patients following the administration of 1 g of vancomycin as a 1 h i.v. infusion. Mean concentrations (range) of vancomycin in lung tissue were 9.6 (6.3-12.1) mg/kg at 1h, 5.7 (4.7-7.4) mg/kg at 2 h, 4.2 (0.8-6.5) mg/kg at 3-4 h, 2.4 (1.4-4.7) mg/kg at 6 h, and 2.8 (0.9-7.8) mg/kg at 12 h after the end of infusion. Ratios of lung tissue to serum concentration ranged 0.24 to 0.41 at 1 and 12 h, respectively. One of six patients observed at 6 h, and 3 of 7 patients at 12 h did not have detectable levels of vancomycin in lung tissue. A 1 h iv infusion of a 1 g dose of vancomycin does not achieve sustained lung concentrations above the MIC for susceptible staphylococci over a dosing interval of 12 h. Therefore, a more appropriate modality of administration, such as continuous infusion, should be considered.
4
Some laboratory and clinical experiences with a new antibiotic, vancomycin.
Geraci Je, Heilman Fr, Nichols Dr · PubMed · 1956 · 182 citations